You go to a professional conference and learn about an exciting new medical innovation. You think it might work at your facility, so you go ahead and authorize its purchase and are ready to go. Then you wake up from your daydream and remember all the steps required to get that exciting new innovation into your facility - if that is even possible. With a sigh, you move on to your next session, thinking, how can we fast-track those medical innovations that could really make a difference in patient outcomes? What would that take? In today's post, we'll look at some of the things your facility can expect if they want to fast-track a medical innovation, and some ideas to make that process successful.

The National Institutes of Health is the largest public funder of biomedical research around the globe. This support has led to life-saving treatments as well as an ever-growing body of research that paves the way for future breakthroughs. NIH funding comes in the form of grants, of which there are dozens of types. In today's post, we'll look at just one type of grant and why it is so important to research in infection control and prevention.

What happens after laboratory tests confirm that an environmental product kills bacteria? Is that the end of the line for testing a product's efficacy? One pair of researchers say no. Here is their proposal for an evidence hierarchy that describes how, in theory, data can begin to connect a product to a reduction in HAIs. While many regulatory agencies exist to protect the consumer by ensuring that HAI reduction claims are true, it is important for us to still be aware of the burden of proof in research, and how that plays out in a laboratory and real-life setting.